Obesity Clinical Trial
Official title:
The Investigation of a Remotely Delivered Behavioral Intervention for Postoperative Weight Regain
Verified date | March 2019 |
Source | Rush University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This project aims to evaluate a newly developed Internet-delivered (via e-learning modules)
acceptance-based behavioral intervention (ABTi) for individuals who are experiencing weight
regain after bariatric surgery. Specifically, the investigators aim to assess ABTi's efficacy
on stopping and/or reversing weight by comparing it to a wait-list control (WLC) condition.
The investigators also aim to evaluate its effect on targeted weight control behaviors and
acceptance-based skills. Finally, the investigators will examine the relationship between
weight outcomes and changes in process variables through exploratory analyses. Treatment
outcomes (i.e., weight, maladaptive behaviors, physical activity, acceptance-based skills)
will be measured at assessments pre-, mid-, and post-treatment, as well as at 3 months after
treatment has ended.
Primary Aims.
1. To test the hypothesis that participants randomly assigned to ABTi will display greater
weight loss from pre- to post-treatment than those assigned to WLC.
2. To test the hypothesis those receiving ABTi, compared to WLC, will display decreased
maladaptive eating behaviors (i.e., loss of control episodes, grazing, emotional eating,
disinhibition), increased physical activity, and greater improvements in
acceptance-based skills (i.e., mindfulness, defusion, food-related acceptance).
Exploratory Aim.
(1) To assess if changes in acceptance-based skills, maladaptive eating behaviors, and
physical activity are associated with pre- to post-treatment weight outcomes.
Status | Completed |
Enrollment | 74 |
Est. completion date | January 31, 2019 |
Est. primary completion date | January 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Has undergone any type of weight loss surgery at least 1.5 years ago - Demonstrate = 10% weight regain of maximum weight loss or 5% of their minimum weight post-surgery, with weight regain lasting for at least 3 months prior to enrollment. - Ability to give consent and speak, write, and understand English. Exclusion Criteria: - Currently enrolled in structured weight loss program - Currently pregnant/plan to become pregnant within 6 months of enrollment - Have a serious medical condition that has the potential of affecting weight or that would prevent engagement in dietary changes and/or an exercise regimen - Exhibit psychiatric symptoms that would interfere with the ability to benefit from the intervention, or report acute suicidality - Non-ambulatory (i.e., unable to walk at least one city block without a cane or walker at the time of screening - Use of medications known to affect body weight, such as chronic systemic steroids or psychiatric medications including lithium, tricyclic antidepressants, and antipsychotic agents |
Country | Name | City | State |
---|---|---|---|
United States | Rush University Medical Center | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
Rush University Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Weight loss | 10 weeks | ||
Secondary | Loss of Control Eating Scale (LOCES) | LOCES measures loss of control eating. | 10 weeks | |
Secondary | Repetitive Eating Assessment-Questionnaire (Rep(eat)) | Rep(eat) measures grazing behaviors. | 10 weeks | |
Secondary | Emotional Eating Scale (EES) | EES will be used to measure emotional eating | 10 weeks | |
Secondary | The Eating Inventory | The Eating Inventory will be used to measure disinhibition. | 10 weeks | |
Secondary | Paffenbarger Physical Activity Recall | Paffenbarger will be used to measure physical activity engagement | 10 weeks | |
Secondary | Philadelphia Mindfulness Scale (PHLMS) | PHLMS will be used to measure mindfulness | 10 weeks | |
Secondary | Drexel Defusion Scale (DDS) | DDS will be used to measure delusion (a psychological construct of cognitive distancing) | 10 weeks | |
Secondary | Food-Related Acceptance and Action Questionnaire (FAAQ) | FAAQ will be used to measure food-related acceptance | 10 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |